Volumetric Mammographic Density, Age-Related Decline, and Breast Cancer Risk Factors in a National Breast Cancer Screening Program

• Published in: Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2018-09, Vol.27 (9), p.1065-1074
• Main Authors: Hjerkind, Kirsti Vik, Ellingjord-Dale, Merete, Johansson, Anna L V, Aase, Hildegunn Siv, Hoff, Solveig Roth, Hofvind, Solveig, Fagerheim, Siri, Dos-Santos-Silva, Isabel, Ursin, Giske
• Format: Article
• Language: English
• Subjects: Medicin och hälsovetenskap
• ISSN: 1055-9965; 1538-7755; 1538-7755
• DOI: 10.1158/1055-9965.EPI-18-0151

Volumetric mammographic density (VMD) measures can be obtained automatically, but it is not clear how these relate to breast cancer risk factors. The cohort consisted of 46,428 women (ages 49-71 years) who participated in BreastScreen Norway between 2007 and 2014 and had information on VMD and breast cancer risk factors. We estimated means of percent and absolute VMD associated with age, menopausal status, body mass index (BMI), and other factors. The associations between VMD and most breast cancer risk factors were modest, although highly significant. BMI was positively associated with absolute VMD, whereas inversely associated with percent VMD. Percent VMD was inversely associated with a 5-year older age at screening in premenopausal and postmenopausal women (-0.18% vs. -0.08% for percent VMD and -0.11 cm vs. -0.03 cm for absolute VMD). This difference was largest among postmenopausal women with BMI < 25 kg/m ( for interaction with percent VMD < 0.0001), never users of postmenopausal hormone therapy ( for interaction < 0.0001), and premenopausal women with a family history of breast cancer ( for interaction with absolute VMD = 0.054). VMD is associated with several breast cancer risk factors, the strongest being BMI, where the direction of the association differs for percent and absolute VMD. The inverse association with age appears modified by menopausal status and other breast cancer risk factors. Because VMD methods are becoming widely available in screening and clinical settings, the association between VMD measures and breast cancer risk factors should be investigated further in longitudinal studies. .